Hydrix eyes Indian med-device cos for tech-transfer to develop products in POC diagnostics
Hydrix from Carnegie is now looking at tapping opportunities in technology transfer and joint product development for range of point-of-care (POC) diagnostics with companies in India.The company is a mobile-wireless technology major and an award winner for developing innovative systems covering implantable, insertables, wearables, in-vitro diagnostics, point of care and laboratory test equipment.
Hydrix from Carnegie, a suburb in the State of Victoria, Australia, a leading software and electronic design consultancy, is now looking at tapping opportunities in technology transfer and joint product development for range of point-of-care (POC) diagnostics with companies in India. The company is a mobile-wireless technology major and an award winner for developing innovative systems covering implantable, insertables, wearables, in-vitro diagnostics, point of care and laboratory test equipment.
Currently, India imports 70 per cent of its diagnostics from various countries and the high rate of custom duty has been detrimental to its indigenous manufacturers. Moreover, the country is home to a large diabetic population estimated at 61 million and there is an increasing incidence of life style disorders including hypertension and cardiovascular disease which requires POC diagnostics. The infusion of embedded technology in diagnostics can revolutionize healthcare in India.
“This is where Hydrix, is keen to chip in its expertise so as to help the Indian medical device industry come out with advanced diagnostics that would help its people in the far-flung remote villages to monitor their health parameters,” Peter Lewis, director, business development, Hydrix told Pharmabiz at the sidelines of interaction.
“India’s domination in information technology and large number of cell phone users, vast population and growing incidence of diseases has created a need for quick tests for early treatment protocols. With a decade of experience, we are now assessing the Indian market to understand the medical device industry and patient needs to tap the opportunities,” he added.
Specifically in India, we are looking at point-of-care and laboratory test equipment. There is also a huge opportunity to develop implantables too. Since, there is an impressive base of nine million cell phone subscribers in a country with 1.2 billion population, we could develop a technology that can be linked to the mobile to test and report the information including ECG to the closest hospitals, said Lewis.
The Indian medical technology industry can build its revenues from its domestic market with advanced and easy to use point of care systems. Hydrix can provide the high quality design software known for both functionality and regulatory compliance like FDA-510K, PMA and De Novo, CE and TGA design for production transfer and validation.
Hydrix has also interacted with over 25 companies in India which are a combination of start-ups and established players to look at collaborations or joint ventures. Considerable interest is evinced and we are hoping these discussions would get converted into potential business deals, said Lewis.
The size of the medical devices sector in Australia is estimated at Aus$ 300 million and Indian market for the same is valued at $2.5 billion in 2012.
The global slowdown of 2009 had impacted for a while but from 2012, there has been an increase in investments by 30 per cent. Even the Victorian Government under its Market Validation Programme has provided an Aus$ 20 million grant for three years for medical devices R&D, said Lewis.
Related News
-
News BioNTech to begin mRNA vaccine manufacturing in Rwanda by 2025
German biotechnology company BioNTech has stated their intentions to begin production at their mRNA vaccine factory in Rwanda by 2025, which will mark the first foreign mRNA vaccine manufacturing site on the continent of Africa. -
News Identifying Alzheimer’s Disease biomarker proteins with whole blood tests
A University of Manchester spin-out pharmaceutical company, PharmaKure, has reported successful study results for the quantification of Alzheimer’s Disease biomarker proteins with a whole blood test. -
News Bill & Melinda Gates Foundation to boost mRNA vaccine initiatives in Africa with USD $40m
To address vaccine inequality and accessibility issues, the Bill & Melinda Gates Foundation aims to deliver USD $40m to various biotech companies and vaccine manufacturers in support of mRNA vaccine development. -
News CPHI Podcast Series: Exploring neurological frontiers in Alzheimer's and beyond
The next episode of the CPHI Podcast Series delves into the science and background behind some recent developments in the field of Alzheimer's disease and neurological disorders. -
News Is patient centricity the future of pharmaceutical manufacturing?
In this interview with Sandra Sánchez y Oldenhage, President of PharmAdvice, she speaks to the importance of considering patients in the manufacturing stages of the pharmaceutical supply chain, and how it can redefine healthcare. -
News CPHI Podcast Series: How to leverage AI for Drug Discovery
Artificial intelligence is the topic of debate in the latest episode from the CPHI Podcast Series, where Digital Editor Lucy Chard speaks with Bill Whitford of DPS Group about the integration of AI in healthcare. -
News Pfizer forges ahead with blood cancer therapy after approval from FDA
Pfizer gains accelerated approval from the US FDA for their new bispecific antibody therapy for multiple myeloma, set to address an unmet need for patients. -
News Alzheimer's drug donanemab deemed effective in landmark clinical trial
Results from the TRAILBLAZER-ALZ 2 Randomised Clinical Trial into the use of donanemab to treat early symptoms of Alzheimer’s disease have been analysed.
Position your company at the heart of the global Pharma industry with a CPHI Online membership
-
Your products and solutions visible to thousands of visitors within the largest Pharma marketplace
-
Generate high-quality, engaged leads for your business, all year round
-
Promote your business as the industry’s thought-leader by hosting your reports, brochures and videos within your profile
-
Your company’s profile boosted at all participating CPHI events
-
An easy-to-use platform with a detailed dashboard showing your leads and performance